Maskless Lithography Announces New MLI-2027 Direct-Write Lithography Tool

Maskless Lithography, Inc., a Silicon Valley startup led by a group of industry veterans, today came out of stealth mode with a brand new direct-write digital imaging technology that will raise the bar in printed circuit board (PCB) production.

The new MLI-2027 direct-write lithography system is the industry's first to combine high throughput and yield with unparalleled accuracy using standard "Non-LDI" resists. Maskless also announced today that Sanmina-SCI Corporation has accepted the first production tool after completing beta testing, validation and qualification of the Maskless MLI-2027 equipment at their San Jose, CA facility.

"The acceptance of this tool marks five years of development coming to fruition," stated Dr. Dan Meisburger, founder and CTO of Maskless Lithography. "In 2005, based upon our founding partners' experience in both lithography and metrology, we identified an opportunity to develop a lithography system that could deliver unrivalled value to the PCB market. We believe we have exceeded that initial vision and are now ready to share this tried and tested capability."

The MLI-2027 is a highly efficient, high throughput PCB production system that can increase the profitability of PCB manufacturers by offering a more cost effective lithography alternative that provides greater yield and ROI compared to other systems on the market. Based on its patented Gray Level Imaging™ (GLI) technology, the MLI-2027 offers unprecedented high printing speed on conventional dry film resists with real-time distortion correction.

"We are really impressed with Maskless' unique direct-write lithography tool," commented Mike Keri, Vice President of Operations for Sanmina-SCI. "The MLI-2027 has allowed us to meet highly challenging designs using conventional dry film resists at high yields and high throughput rates."

Source: http://www.maskless.com

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.